World / Only US agencies couldn't grasp benefits of HCQ: Trump as FDA revokes emergency use

US President Donald Trump has said other countries had provided great reports on effectiveness of Hydroxychloroquine (HCQ) for treatment of COVID-19, adding that only US agencies have failed to grasp its benefits. This comes after US Food and Drug Administration (FDA) revoked its emergency use authorisation for HCQ to treat COVID-19. Trump has in the past praised the drug's usefulness.

Reuters : Jun 16, 2020, 01:57 PM
WASHINGTON - President Donald Trump said on Monday other countries had provided great reports on the effectiveness of malaria drug hydroxychloroquine for treatment of the deadly coronavirus, complaining that only U.S. agencies have failed to grasp its benefit.

His remarks, delivered to reporters at the White House, came hours after the U.S. Food and Drug Administration revoked its emergency use authorization for hydroxychloroquine to treat COVID-19, despite Trump’s frequent praise of the drug’s usefulness for staving off the disease.